Telmirow Plus Tablets 80/12.5 mg

Adult dose

In patients whose blood pressure is not adequately controlled with Telmisartan alone, this medication should be taken once daily, with or without food, along with a drink. It is recommended that the dosage of each component be adjusted according to the individual before switching to this fixed-dose combination medication. When clinically appropriate, switching from monotherapy to this medication can be considered. - Telmisartan/Hydrochlorothiazide combination 40/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with 40 mg of Telmisartan. - Telmisartan/Hydrochlorothiazide combination 80/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with 80 mg of Telmisartan. - Telmisartan/Hydrochlorothiazide combination 80/25 mg may be administered to patients whose blood pressure is not adequately controlled with the combination or single agent of 80 mg of Telmisartan and 12.5 mg of Hydrochlorothiazide. Before starting this medication, sodium or volume depletion should be corrected. Renal impairment patients No dosage adjustment is required for patients with mild to moderate renal impairment. This medication is not to be administered to patients with severe renal impairment (creatinine clearance <30 mL/min). Regular monitoring of kidney function is recommended. Hepatic impairment patients This medication should be used with caution in patients with mild to moderate hepatic impairment. The maximum dose should not exceed 40/12.5 mg once daily. This medication should not be administered to patients with severe hepatic impairment (refer to precautions in usage). Thiazide diuretics should be used with caution in patients with liver dysfunction. Elderly No dosage adjustment is necessary. Children Safety and efficacy in patients under 18 years of age have not been established.

Child dose

Safety and efficacy in patients under 18 years of age have not been established.

This medication can pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any ingredients in this medication, those with certain liver or kidney conditions, pregnant women, and nursing mothers should not take this medication. Elderly patients or those with certain heart and vascular diseases, as well as patients with high potassium levels or impaired liver function, should use this medication cautiously. As this medication lowers blood pressure, symptoms of hypotension such as dizziness and fainting may occur; care should be taken during treatment to observe for these symptoms. The hydrochlorothiazide component can cause electrolyte imbalances, so potassium, sodium, and magnesium levels in the blood should be monitored regularly. Additionally, this medication may increase skin sensitivity to sunlight, so attention should be given to sun protection during treatment, and any new skin lesions should be reported to a doctor immediately. There are many drug interactions with this medication, so especially when taken in combination with diuretics, lithium, antihypertensives, and anti-inflammatory drugs, consultation with a doctor and periodic monitoring are required. In cases of overdose, hypotension, electrolyte abnormalities, and dehydration may occur, and immediate consultation with a healthcare facility is necessary, with treatment proceeding according to symptoms. Safety for children has not been established, so it is not recommended for use in children, and caution should be exercised in elderly patients to avoid excessive blood pressure reduction. Store this medication out of reach of children, and use it immediately after removing it from the packaging.

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, wheezing or difficulty in breathing, asthma attack, cough with fever-associated respiratory abnormalities, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, lightning headaches, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output, severe swelling of the body associated with hypertension, angioedema (life-threatening)

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disorders, dizziness, visual disturbances, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, respiratory distress, pneumonia, diarrhea, dry mouth, bloating, abdominal pain, constipation, dyspepsia, vomiting, liver function abnormalities/liver disorders, erythema, pruritus, rash, urticaria, low back pain, muscle spasms, muscle pain

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It should also be stored at room temperature between 1°C and 30°C, away from direct sunlight.

Appearance

White or off-white, bilaterally convex, round tablet

Package unit

10 tablets/blister [X 3], 100 tablets/bottle